Wealth Enhancement Advisory Services »

Aurinia Pharmaceuticals shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $385k 24k 15.78
2025-12-31 $220k 14k 15.44
2025-09-30 $134k 11k 11.71
2025-06-30 $99k 13k 7.59
2025-03-31 $86k 11k 8.04

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation Put Option (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Intl Moment (IMTM)
Micron Technology (MU)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
Goldman Sachs Group
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Marshall Wace
Geode Capital Management
Renaissance Technologies
D. E. Shaw & Co
Vanguard Portfolio Management
Jacobs Levy Equity Management
Caption Management

View all funds holding Aurinia Pharmaceuticals